XT
VRTX icon

XTX Topco’s Vertex Pharmaceuticals VRTX Stock Holding History

XTX Topco’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,632
Closed -$6.98M – 4760
2026
Q1 		$6.98M Buy
+15,632
New +$7.29M 0.12% 158
2025
Q4 		– Sell
-9,690
Closed -$3.79M – 3859
2025
Q3 		$3.79M Buy
9,690
+5,165
+114% +$2.16M 0.2% 64
2025
Q2 		$2.01M Buy
+4,525
New +$2.09M 0.08% 329
2025
Q1 		– Sell
-2,530
Closed -$1.02M – 3178
2024
Q4 		$1.02M Buy
+2,530
New +$1.17M 0.08% 289
2024
Q3 		– Sell
-8,449
Closed -$3.96M – 2657
2024
Q2 		$3.96M Buy
+8,449
New +$3.67M 0.34% 19
2024
Q1 		– Sell
-2,718
Closed -$1.11M – 2368
2023
Q4 		$1.11M Sell
2,718
-4,351
-62% -$1.61M 0.24% 24
2023
Q3 		$2.46M Buy
7,069
+4,270
+153% +$1.49M 0.42% 8
2023
Q2 		$985K Buy
2,799
+1,170
+72% +$394K 0.18% 90
2023
Q1 		$513K Buy
1,629
+774
+91% +$232K 0.11% 276
2022
Q4 		$247K Sell
855
-1,054
-55% -$321K 0.05% 709
2022
Q3 		$553K Buy
1,909
+967
+103% +$278K 0.14% 206
2022
Q2 		$265K Sell
942
-1,239
-57% -$332K 0.11% 324
2022
Q1 		$569K Sell
2,181
-1,073
-33% -$255K 0.25% 113
2021
Q4 		$715K Buy
+3,254
New +$633K 0.4% 38

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

XTX Topco's VRTX Position: Q2 2026 in Review

XTX Topco sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 15,632 shares — an estimated $6.98M sold.

XTX Topco first reported a position in VRTX in Q4 2021 and held it in 14 quarters. The position peaked at $6.98M in Q1 2026. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • XTX Topco reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 15,632 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.98M.
  • XTX Topco first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • XTX Topco's Vertex Pharmaceuticals position peaked at $6.98M in Q1 2026.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.